India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Metabolic hypogonadism, a condition marked by low testosterone levels and frequently seen in obese individuals, contributes ...

A WOMAN has revealed that she has shed 7kg without the help of Mounjaro. Since becoming available on the NHS earlier this ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

The incretin-based therapies reduced mortality and hospitalization risk in individuals with heart failure with preserved ...

The illicit supply of unregulated weight loss drugs is becoming an ‘emerging concern’ for Police Scotland and the.